Sherie Ramsgard
Psychiatric/Mental Health · Syracuse, NYNPI 1457305534
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $42,625 of the $52,429 with a category attached, or 81.3%. AbbVie accounts for 89.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $21,597 and has fallen 53.8% since, to $9,973 in 2025. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 397 payments — averaging $132.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$47K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$852
- Teva Pharmaceuticals USA, Inc.$838
- Lundbeck LLC$720
- Axsome Therapeutics, Inc.$551
- Otsuka America Pharmaceutical, Inc.$536
- plus $2K from 11 others
What the payments were for
- Speaking & faculty fees$42,62581%
- Travel & lodging$2,3284%
- Food & beverage$7,37514%
- Education$1010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 187 | $47,091 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $852 |
| Teva Pharmaceuticals USA, Inc. | 30 | $838 |
| Lundbeck LLC | 44 | $720 |
| Axsome Therapeutics, Inc. | 15 | $551 |
| Otsuka America Pharmaceutical, Inc. | 15 | $536 |
| Johnson & Johnson | 13 | $471 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $373 |
| Sunovion Pharmaceuticals Inc. | 20 | $361 |
| Supernus Pharmaceuticals, Inc. | 10 | $265 |
| Neurocrine Biosciences, Inc. | 3 | $77 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| Corium, LLC | 4 | $67 |
| Alkermes, Inc. | 3 | $63 |
| Almatica Pharma LLC | 3 | $58 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Neos Therapeutics, LP | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$44,380
- UZEDY$230
- REXULTI$229
- CAPLYTA$224
- Auvelity$209
- Austedo XR$207
- INVEGA SUSTENNA$123
- QELBREE$103
How this compares
$52,429 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 14 | $22,325 |
| TrintellixVortioxetine Hydrobromide | 21 | $18,402 |
| Bupropion XlBupropion Hcl | 45 | $944 |
| Duloxetine Hcl | 39 | $867 |
| Alprazolam | 64 | $541 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $532 |
| Olanzapine | 28 | $477 |
| Sertraline Hcl | 54 | $452 |
| Clozapine | 11 | $399 |
| Temazepam | 22 | $343 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $322 |
| Clonazepam | 23 | $198 |
| Lorazepam | 33 | $172 |
| Fluoxetine Hcl | 105 | $172 |
| Trazodone Hcl | 25 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $536 | $22,32514 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $373 | $18,40221 claims |
| Almatica Pharma LLCSertraline Hcl | $58 | $45254 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Other psychiatric/mental health in Syracuse
- Laneasha EudellSyracuse$15K
- Kyle GroshansSyracuse$10K
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.